LAS VEGAS, May 23, 2017, GBLX, /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce the filing of its latest patent application by its wholly-owned subsidiary, Growblox Life Sciences, LLC for the treatment of chronic pain and heart therapies based on myrcene-containing complex mixtures (“MCCM”). The current US opioid epidemic, along with growing public and government concern regarding opioid abuse, makes new pain treatments a promising field of research and development. Our novel pain formulations are also substantially free ofRead more
- Vertically integrated cannabis firm Ascend Wellness raises $55 million for expansion
- Lifeline Biotechnologies Updates Shareholders and The Public
- Financial Gravity Selects Securities Transfer Corporation as Transfer Agent
- Wayfair Reports 58% Increase in Direct Retail Sales for Peak Five-Day Holiday Shopping Weekend
- Marijuana tech firm Metrc gets $50M with help from Snoop Dogg, Tiger Global
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More